Last week, medical affairs leaders gathered in London for NextLevel’s Medical Affairs Forum. At the congress, I was honored to chair the Best Practices in Late Phase Research track and meet with many industry leaders. Presenters shared their innovative views on integrating real-world evidence within product lifecycle strategies along with perspectives on study design and implementation challenges and opportunities.
real-world evidence for pharmaceuticals
There is increasing demand from payers to gather evidence on the safety of medications used in the general population post-commercialization. Conducting a literature review involving critical appraisal is essential to better understand the research topic and assess the validity of the research findings. UBC can conduct literature reviews and other real-world evidence generation studies for your product.
The industry has shifted to a proactive approach to real-world evidence, collecting data earlier in the clinical trial process – often as early as Phase II. UBC experts will present strategies for optimizing study design to meet real-world evidence needs at CBI's Evidence for Value-Based Programs in Boston.